These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11224516)
1. Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation. Ugolini S; Vivier E Nat Immunol; 2001 Mar; 2(3):198-200. PubMed ID: 11224516 [No Abstract] [Full Text] [Related]
2. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Groh V; Rhinehart R; Randolph-Habecker J; Topp MS; Riddell SR; Spies T Nat Immunol; 2001 Mar; 2(3):255-60. PubMed ID: 11224526 [TBL] [Abstract][Full Text] [Related]
4. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood. Warren HS; Rana PM; Rieger DT; Hewitt KA; Dahlstrom JE; Kent AL J Leukoc Biol; 2006 Jun; 79(6):1252-9. PubMed ID: 16574769 [TBL] [Abstract][Full Text] [Related]
5. Expression of inhibitory receptors for MHC class I molecules on T cells. Huard B Crit Rev Immunol; 2000; 20(6):471-6. PubMed ID: 11396682 [TBL] [Abstract][Full Text] [Related]
6. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I. von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431 [TBL] [Abstract][Full Text] [Related]
7. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes. Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220 [TBL] [Abstract][Full Text] [Related]
8. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769 [TBL] [Abstract][Full Text] [Related]
9. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Pyzik M; Kielczewska A; Vidal SM Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016 [TBL] [Abstract][Full Text] [Related]
10. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Ugolini S; Arpin C; Anfossi N; Walzer T; Cambiaggi A; Förster R; Lipp M; Toes RE; Melief CJ; Marvel J; Vivier E Nat Immunol; 2001 May; 2(5):430-5. PubMed ID: 11323697 [TBL] [Abstract][Full Text] [Related]
11. MHC class I receptors on natural killer cells: on with the old and in with the new. Khakoo SI; Brooks CR Clin Sci (Lond); 2003 Aug; 105(2):127-40. PubMed ID: 12737620 [TBL] [Abstract][Full Text] [Related]
12. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. López-Botet M; Angulo A; Gumá M Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708 [TBL] [Abstract][Full Text] [Related]
13. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674 [TBL] [Abstract][Full Text] [Related]
14. A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo. Carey B; DeLay M; Strasser JE; Chalk C; Dudley-McClain K; Milligan GN; Brunner HI; Thornton S; Hirsch R Clin Immunol; 2005 Jul; 116(1):65-76. PubMed ID: 15925833 [TBL] [Abstract][Full Text] [Related]
15. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I. Rabinovich BA; Li J; Hurren R; Miller RG Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of cytotoxic T-lymphocyte activation by soluble CD8. Sewell AK; Gerth UC; Price DA; Purbhoo MA; Boulter JM; Gao GF; Bell JI; Phillips RE; Jakobsen BK Nat Med; 1999 Apr; 5(4):399-404. PubMed ID: 10202928 [TBL] [Abstract][Full Text] [Related]
17. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564 [TBL] [Abstract][Full Text] [Related]
18. MHC class I molecules and KIRs in human history, health and survival. Parham P Nat Rev Immunol; 2005 Mar; 5(3):201-14. PubMed ID: 15719024 [TBL] [Abstract][Full Text] [Related]
19. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells. Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291 [TBL] [Abstract][Full Text] [Related]
20. Human NK cell education by inhibitory receptors for MHC class I. Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]